EUVIMED · CrossrefJournal
International Journal of Neonatal Screening
ISSN 2409-515X · MDPI AG
Latest articles
Correction: Camacho et al. Evaluating the Impact of Newborn Screening for Cystic Fibrosis in Portugal: A Decade of Insights and Outcomes. Int. J. Neonatal Screen. 2025, 11, 69
The Association of Gestational Age, Birth Weight, and Age at Heel Prick with Biomarkers of Newborn Screening in The Netherlands
Loss to Diagnostic Follow-Up After Universal Newborn Hearing Screening in Well Infants: A Cohort Study
Newborn Screening Equity in Spain: Progress and Persistent Gaps
Multi-Modal Recruitment Efficiency in ScreenPlus, a Large-Scale Consented Pilot NBS Program
Integrating Hearing-Targeted Congenital Cytomegalovirus Follow-Up into Existing Newborn Screening Infrastructure: Georgia’s Experience
“Spit Happens”: Why We Must Approach Saliva-Based Congenital CMV Screening with Caution. Comment on Santander et al. Consented Universal Newborn Screening for Congenital Cytomegalovirus Infection Using Dried Blood Spot and Dried Saliva Spot Specimens: Implementation and Relative Programmatic Accuracy. Int. J. Neonatal Screen. 2026, 12, 85
Nationwide Pilot Newborn Screening for Spinal Muscular Atrophy and Inborn Errors of Immunity in Greece
Two-Year Nationwide Newborn Screening for Severe Combined Immunodeficiency in Latvia—The First Experience in Baltic Countries
Restarting the Recommended Uniform Screening Panel (RUSP) Process: A New Way Forward for Newborn Screening in the United States
Performance Evaluation of Newborn Screening for Congenital Adrenal Hyperplasia: A Single Health System Clinical Audit in Pakistan
United States Public Health Laboratory Experiences with Krabbe Disease Newborn Screening After Recommendation at the National Level
A Decade of Neonatal Inherited Metabolic Disorder Screening Experience in Ningbo, China: Screening Performance, Disease Spectrum, and Genetic Characteristics
Haemoglobinopathies in Newborn Screening: Epidemiological Findings and Exploratory Analysis of HbA0 Distribution in a Population-Based Neonatal Cohort from Northern Italy
Five Years of Newborn Screening for Lysosomal Disorders in Indiana
Consented Universal Newborn Screening for Congenital Cytomegalovirus Infection Using Dried Blood Spot and Dried Saliva Spot Specimens: Implementation and Relative Programmatic Accuracy
Refining MMA Screening in the Dutch Newborn Screening Program: Lessons from Vitamin B12 Deficiency and Genetic Cases
Optimizing Kappa-Deleting Recombination Excision Circles (KREC) Cut-Off Values in Russian Newborn Screening Program: Balancing Sensitivity and False-Positive Rates
The Spanish Uniform Newborn Screening Panel (SUSP): A National Consensus Framework for Harmonized Newborn Screening
Mucopolysaccharidosis Type II Screening, Diagnosis, and Management: A Literature Review and Practical Recommendations for Newborn Screening Programs and Health Care Providers to Support Families and Improve Outcomes
Optimizing Informed Consent for Australian Newborn Bloodspot Screening and Research: Consensus Workshop Insights and Recommendations
Features and Legal Practice of Dried Blood Spot Card Biobanking in Europe: Balancing Research Potential with Parental and Children’s Rights
Attitudes Toward Sex-Specific Versus Universal Newborn Screening for X-Linked Adrenoleukodystrophy in Hong Kong
A Comprehensive Meta-Analytical Investigation into the Incidence of Neonatal Amino Acid Metabolic Disorders Across China
Experience with Implementation of Pulse Oximetry Screening for Critical Congenital Heart Disease in a Low–Middle-Income Country
Homozygosity for a Clinically Significant GALC Haplotype Associated with Late-Infantile Krabbe Disease Detected on Newborn Screening: Implications for Clinical Management and Genetic Counseling
Cystic Fibrosis Newborn Screening: Progress and Perspectives
Newborn Screening for Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency and Analysis of SLC25A13 Gene Mutations in Hefei, China
Communicating a Congenital Cytomegalovirus Diagnosis: Parent Experiences and a Clinical Framework
Improving Severe Combined Immunodeficiency and Cystic Fibrosis Newborn Screening by Replacing Current Tests with First-Tier Targeted Gene Sequencing
EUVIMED